Princeton Capital Management LLC Concert Pharmaceuticals, Inc. Transaction History

Princeton Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$5.71 - $9.22 $18,129 - $29,273	-3,175 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$9.44 - $13.12 $130,385 - $181,213	-13,812 Reduced 81.31%	3,175 $38,000
Q1 2019 May 02, 2019	SELL	$12.07 - $17.54 $10,863 - $15,786	-900 Reduced 5.03%	16,987 $205,000
Q4 2018 Feb 13, 2019	BUY	$11.25 - $16.17 $9,360 - $13,453	832 Added 4.88%	17,887 $224,000
Q3 2018 Nov 08, 2018	BUY	$12.82 - $17.88 $6,063 - $8,457	473 Added 2.85%	17,055 $253,000
Q1 2018 May 03, 2018	BUY	$19.24 - $28.03 $13,467 - $19,621	700 Added 4.41%	16,582 $380,000
Q4 2017 Feb 12, 2018	BUY	$13.96 - $29.05 $221,712 - $461,372	15,882	15,882 $411,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Princeton Capital Management LLC with notifications on news.